Literature DB >> 16755156

Renovascular hypertension: a unique cause of unilateral focal segmental glomerulosclerosis.

Bassam Alchi1, Arimasa Shirasaki, Ichiei Narita, Shinichi Nishi, Mitsuhiro Ueno, Takako Saeki, Shoji Miyamura, Fumitake Gejyo.   

Abstract

A 48-year-old man presented with malignant hypertension and massive proteinuria. Renal angiography showed complete obstruction of the left renal artery and 99mTc-mercaptoacetylglycine (MAG3) renography showed a nonfunctioning left kidney. Percutaneous transluminal renal angioplasty of the left renal artery was unsuccessful; hence, the patient underwent left nephrectomy because of uncontrolled hypertension and proteinuria. Histological examination of a right kidney specimen revealed lesions of focal segmental glomerulosclerosis with benign nephrosclerosis. In contrast, histology of the left kidney showed typical ischemic kidney with hypertrophy of arteriolar smooth muscle cells. The patient responded favorably to the nephrectomy, as his blood pressure and urinary protein dramatically decreased with no antihypertensive medication. This case illustrates the heterogeneous effect of the renin-angiotensin system on either kidney in patients with renovascular hypertension due to unilateral renal artery stenosis.

Entities:  

Mesh:

Year:  2006        PMID: 16755156     DOI: 10.1291/hypres.29.203

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension.

Authors:  Kumiko Fukuda; Akira Shimizu; Tomohiro Kaneko; Yukinari Masuda; Fumihiko Yasuda; Megumi Fukui; Seiichiro Higo; Akio Hirama; Akiko Mii; Shuichi Tsuruoka; Ryuji Ohashi; Yasuhiko Iino; Yuh Fukuda; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-12-07

2.  Endovascular treatment of renal artery stenosis improves contralateral renal hypertrophy with nephrotic syndrome.

Authors:  Hiromichi Wakui; Yuki Hosokawa; Jin Oshikawa; Kouichi Tamura; Yoshiyuki Toya; Machiko Yabana; Shuta Furihata; Teruyasu Sugano; Satoshi Umemura
Journal:  CEN Case Rep       Date:  2013-06-17

3.  Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.

Authors:  Michio Nagata; Yutaka Yamaguchi; Daisuke Toki; Izumi Yamamoto; Hiroaki Shinmura; Hiroshi Kawaguchi
Journal:  CEN Case Rep       Date:  2016-09-26

4.  Ultrastructural pathological features of unilateral renal artery stenosis in the rats.

Authors:  Xin Liu; Yonghui Mao; Xuemei He; Mei Wang; Liangying Gan
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 5.  Current Concepts in the Treatment of Renovascular Hypertension.

Authors:  Sandra M Herrmann; Stephen C Textor
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

6.  Regional secondary focal segmental glomerulosclerosis in a transplanted kidney: resolution with treatment of a segmental renal artery stenosis.

Authors:  Daiki Iwami; Hiroshi Harada; Hiroaki Usubuchi; Kiyohiko Hotta; Toshimori Seki; Masaki Togashi; Yuichiro Fukasawa
Journal:  BMC Nephrol       Date:  2012-06-12       Impact factor: 2.388

7.  Successful percutaneous transluminal angioplasty for the treatment of renovascular hypertension with an atrophic kidney.

Authors:  Keisuke Maruyama; Junko Chinda; Maki Kabara; Naoki Nakagawa; Takayuki Fujino; Toshiharu Takeuchi; Naoyuki Hasebe
Journal:  Heart Vessels       Date:  2014-01-03       Impact factor: 2.037

8.  Steroid-responsive nephrotic syndrome and bilateral renal artery stenosis: a possible role for Angiotensin-mediated podocyte injury.

Authors:  Rahul Bhardwaj; Imran Dosani; Barbara A Clark
Journal:  Case Rep Nephrol Urol       Date:  2012-06-05

9.  A case report of successfully treated nephrotic syndrome after renal angioplasty.

Authors:  Hee Jung Park; Ha Nee Jang; Hyun Seop Cho; Se-Ho Chang; Hyun-Jung Kim
Journal:  BMC Nephrol       Date:  2019-08-06       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.